These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37992186)

  • 41. Effect of sugar-free Qishan granules on glucose and lipid metabolism and insulin resistance in a rat model of prediabetes.
    Wei Y; Hong Y; Hou P; Xu X
    J Tradit Chin Med; 2019 Aug; 39(4):535-541. PubMed ID: 32186101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT).
    Kabisch S; Meyer NMT; Honsek C; Gerbracht C; Dambeck U; Kemper M; Osterhoff MA; Birkenfeld AL; Arafat AM; Weickert MO; Pfeiffer AFH
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
    Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial.
    Andriessen C; Fealy CE; Veelen A; van Beek SMM; Roumans KHM; Connell NJ; Mevenkamp J; Moonen-Kornips E; Havekes B; Schrauwen-Hinderling VB; Hoeks J; Schrauwen P
    Diabetologia; 2022 Oct; 65(10):1710-1720. PubMed ID: 35871650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Faecal microbial metabolites of proteolytic and saccharolytic fermentation in relation to degree of insulin resistance in adult individuals.
    Hernández MAG; Canfora EE; Blaak EE
    Benef Microbes; 2021 Jun; 12(3):259-266. PubMed ID: 33880973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.
    Stefan N; Staiger H; Wagner R; Machann J; Schick F; Häring HU; Fritsche A
    Diabetologia; 2015 Dec; 58(12):2877-84. PubMed ID: 26404062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.
    Schmid V; Wagner R; Sailer C; Fritsche L; Kantartzis K; Peter A; Heni M; Häring HU; Stefan N; Fritsche A
    Diabetologia; 2017 Dec; 60(12):2341-2351. PubMed ID: 28840257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
    Chen X; Maldonado E; DeFronzo RA; Tripathy D
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1398-1409. PubMed ID: 33524152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycemic and Insulin Status in Periodontitis Patients using the Homeostasis Model Assessment (HOMA): A Pilot Study.
    Gerin E; Buysschaert M; Lasserre JF; Leprince JG; Toma S
    Oral Health Prev Dent; 2023 Jan; 21():2-6. PubMed ID: 36651310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.
    George L; Bacha F; Lee S; Tfayli H; Andreatta E; Arslanian S
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2136-45. PubMed ID: 21508130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between site-specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women.
    Kim SM; Cui J; Rhyu J; Guo X; Chen YI; Hsueh WA; Rotter JI; Goodarzi MO
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):848-855. PubMed ID: 29575061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.
    Panigrahi A; Mohanty S
    BMC Endocr Disord; 2023 Sep; 23(1):190. PubMed ID: 37679692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increase in testosterone levels is related to a lower risk of conversion of prediabetes to manifest diabetes in prediabetic males.
    Leutner M; Matzhold C; Bellach L; Wohlschläger-Krenn E; Winker R; Nistler S; Endler G; Thurner S; Klimek P; Kautzky-Willer A
    Wien Klin Wochenschr; 2022 Jan; 134(1-2):1-6. PubMed ID: 34223999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
    Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
    Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history and determinants of dysglycemia in Canadian children with parental obesity from ages 8-10 to 15-17 years: The QUALITY cohort.
    Harnois-Leblanc S; Van Hulst A; Ybarra M; Barnett TA; Mathieu MÈ; McGrath JJ; Tremblay A; Paradis G; Drapeau V; Sylvestre MP; Henderson M
    Pediatr Diabetes; 2022 May; 23(3):274-285. PubMed ID: 35023257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome.
    Vetrani C; Costabile G; Luongo D; Naviglio D; Rivellese AA; Riccardi G; Giacco R
    Nutrition; 2016 Feb; 32(2):217-21. PubMed ID: 26706023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.
    Ebenibo S; Edeoga C; Wan J; Dagogo-Jack S
    Metabolism; 2014 Jun; 63(6):767-72. PubMed ID: 24641885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Metabolism; 2004 Apr; 53(4):414-22. PubMed ID: 15045685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression of particular glucose transporters and insulin resistance indicators in the risk groups of type 2 diabetes--a two-year follow-up.
    Bernat-Karpińska M; Piątkiewicz P; Czech A; Wierzbicki P
    Endokrynol Pol; 2012; 63(3):212-9. PubMed ID: 22744628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.